ArticleBMC cancer2016

A retrospective study of predictive factors for unexpectedly prolonged or shortened progression-free survival and overall survival among patients with metastatic renal cell carcinoma who received first-line targeted therapy.

Sung Han Kim et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.